Fungal secondary metabolites (SMs) represent an invaluable source of therapeutic drugs. Genomics-based approaches to SM discovery have revealed a vast and largely untapped biosynthetic potential within fungal genomes. Here. we used the publicly available fungal genome sequences from the NCBI public database. https://www.hindirochakkahaniya.com/